Laboratorios Farmaceuticos Rovi, S.A. Stock OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
09:30:03 2026-08-03 EDT
|
5-day change | 1st Jan Change | ||
| 67.17 USD | +1.98% |
|
-.--% | +1.98% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.03B 3.52B 2.85B 2.61B 4.88B 333B 4.89B 33.72B 13.08B 171B 13.23B 12.95B 550B | P/E 2026 * |
21.2x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.02B 3.51B 2.84B 2.59B 4.85B 331B 4.86B 33.54B 13.01B 170B 13.16B 12.88B 547B | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 3.31x |
| Free-Float |
31.63% | Yield 2026 * |
1.65% | Yield 2027 * | 1.97% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Tradegate
| 41L | Real-time | |
|
Berne S.E.
| 41L | End-of-day quote | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript : Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | +1.98% | ||
| 3 months | +1.98% | ||
| 6 months | +1.98% | ||
| Current year | +1.98% |
| Current year | 67.17 |  | 67.17 |
| 1 year | 67.17 | | 67.17 |
| 3 years | 52 | | 90.61 |
| 5 years | 0.03 | | 90.61 |
| 10 years | 0.03 | | 90.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.98% | -.--% | - | - | 3.52B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | |
| Average | -0.69% | +1.09% | +28.30% | +51.13% | 408.71B | |
| Weighted average by Cap. | -1.10% | +0.55% | +36.62% | +66.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 897M 726M 663M 1.24B 84.67B 1.24B 8.58B 3.33B 43.44B 3.37B 3.29B 140B | 891M 1.04B 838M 766M 1.43B 97.74B 1.44B 9.9B 3.84B 50.15B 3.89B 3.8B 162B |
| Net income | 129M 149M 121M 110M 207M 14.1B 207M 1.43B 555M 7.24B 561M 549M 23.31B | 174M 202M 164M 149M 280M 19.08B 280M 1.93B 750M 9.79B 759M 742M 31.54B |
| Net Debt | -16.21M -18.84M -15.25M -13.94M -26.07M -1.78B -26.14M -180M -69.95M -913M -70.75M -69.21M -2.94B | -81.51M -94.72M -76.69M -70.05M -131M -8.94B -131M -906M -352M -4.59B -356M -348M -14.78B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- LABFF Stock
Select your edition
All financial news and data tailored to specific country editions
